Carol Chen

8.2k citations

56 papers · 2.0k indexed · 1 hit paper · h-index 16

Impact in

Molecular Biology top 10%
- Genomics and Chromatin Dynamics
- Epigenetics and DNA Methylation
- Bioinformatics and Genomic Networks
- RNA modifications and cancer
- RNA Research and Splicing
Cancer Research top 10%
- Cancer-related molecular mechanisms research

Papers in ⓘ

Transplantation 5
- Renal Transplantation Outcomes and Treatments 5
Hematology 20
- Hematopoietic Stem Cell Transplantation 20
- Acute Myeloid Leukemia Research 9

Co-authors: Robert E. W. Hancock (2 shared papers)Raymond Lo (1 shared paper)David J. Lynn (1 shared paper)Fiona S. L. Brinkman (1 shared paper)Amir Foroushani (1 shared paper)Matthew R. Laird (1 shared paper)Karin Breuer (1 shared paper)Geoffrey L. Winsor (1 shared paper)
Journals: European Journal Of Haematology (7 papers)Transplantation and Cellular Therapy (7 papers)Journal of Clinical Oncology (3 papers)Nature Communications (2 papers)Molecular Cell (2 papers)
Partner nations: Canada United States Sweden

In The Last Decade

Carol Chen

51 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation 2012 · 858 citations

Peers

Countries citing papers authored by Carol Chen

Since Specialization

Citations

This map shows the geographic impact of Carol Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Chen more than expected).

Fields of papers citing papers by Carol Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Chen. The network helps show where Carol Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Carol Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carol Chen Line = papers co-authored together Carol Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation Nucleic Acids Research ·Karin Breuer, Amir Foroushani, Matthew R. Laird, Carol Chen, Anastasia Sribnaia, Raymond Lo, Geoffrey L. Winsor, Robert E. W. Hancock, Fiona S. L. Brinkman, David J. Lynn Hit paper breakdown →	2012	858
2	An ultra-low-input native ChIP-seq protocol for genome-wide profiling of rare cell populations Nature Communications ·Julie Brind’Amour, Sheng Liu, Matthew B. Hudson, Carol Chen, Mohammad M. Karimi, Matthew C. Lorincz	2015	275
3	Dynamic and flexible H3K9me3 bridging via HP1β dimerization establishes a plastic state of condensed chromatin Nature Communications ·Kyoko Hiragami-Hamada, Szabolcs Soeroes, Miroslav Nikolov, Bryan J. Wilkins, Sarah Kreuz, Carol Chen, Inti A. De La Rosa-Velázquez, Hans Michael Zenn, Nils Kost, Wiebke H. Pohl, Aleksandar Chernev, Dirk Schwarzer, Thomas Jenuwein, Matthew C. Lorincz, Bastian Zimmermann, Peter Jomo Walla, Heinz Neumann, Tuncay Baubec, Henning Urlaub, Wolfgang Fischle	2016	108
4	Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib Clinical Cancer Research ·Patrick G. Morris, Carol Chen, Richard M. Steingart, Martin Fleisher, Nancy U. Lin, Beverly Moy, Steven E. Come, Steven Sugarman, A. Abbruzzi, Robert Lehman, Sujata Patil, Maura N. Dickler, Heather L. McArthur, Eric P. Winer, Larry Norton, Clifford A. Hudis, Chau T. Dang	2011	101
5	Smad3 binds scleraxis and mohawk and regulates tendon matrix organization Journal of Orthopaedic Research® ·Ellora Berthet, Carol Chen, Kristin Butcher, Richard A. Schneider, Tamara Alliston, Mohana Amirtharajah	2013	78
6	Synthetic Cationic Peptide IDR-1018 Modulates Human Macrophage Differentiation PLoS ONE ·Olga M. Pena, Nicole Afacan, Jelena Pistolic, Carol Chen, Laurence Madera, Reza Falsafi, Christopher D. Fjell, Robert E. W. Hancock	2013	77
7	MYOCARDITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS Journal of the American College of Cardiology ·Syed Mahmood, Michael G. Fradley, Justine V. Cohen, Anju Nohria, Kerry L. Reynolds, Lucie Heinzerling, Ryan J. Sullivan, Rongras Damrongwatanasuk, Carol Chen, Dipti Gupta, Michael Constantin Kirchberger, Javid J. Moslehi, Sachin J. Shah, Sarju Ganatra, Paaladinesh Thavendiranathan, Donald P. Lawrence, John D. Groarke, Tomas G. Neilan	2018	71
8	hnRNP K Coordinates Transcriptional Silencing by SETDB1 in Embryonic Stem Cells PLoS Genetics ·Peter J. Thompson, Vered Dulberg, Kyung-Mee Moon, Leonard J. Foster, Carol Chen, Mohammad M. Karimi, Matthew C. Lorincz	2015	59
9	Dose-Dense Doxorubicin and Cyclophosphamide Followed by Weekly Paclitaxel With Trastuzumab and Lapatinib in HER2/neu–Overexpressed/Amplified Breast Cancer Is Not Feasible Because of Excessive Diarrhea Journal of Clinical Oncology ·Chau T. Dang, Nancy U. Lin, Beverly Moy, Steven E. Come, Steven Sugarman, Patrick G. Morris, A. Abbruzzi, Carol Chen, Richard M. Steingart, Sujata Patil, Larry Norton, Eric P. Winer, Clifford A. Hudis	2010	36
10	H3S10ph broadly marks early-replicating domains in interphase ESCs and shows reciprocal antagonism with H3K9me2 Genome Research ·Carol Chen, Preeti Goyal, Mohammad M. Karimi, Marie H. Abildgaard, Hiroshi Kimurâ, Matthew C. Lorincz	2017	30
11	Histone H3.3 K27M and K36M mutations de-repress transposable elements through perturbation of antagonistic chromatin marks Molecular Cell ·Amel Chaouch, Johannes Berlandi, Carol Chen, Felice Frey, Shireen Badini, Ashot S. Harutyunyan, Xiao Chen, Brian Krug, Steven Hébert, Astrid Jeibmann, Chao Lü, Claudia L. Kleinman, Martin Hasselblatt, Paul Lasko, Margret Shirinian, Nada Jabado	2021	29
12	Dose-Dense Adjuvant Doxorubicin and Cyclophosphamide Is Not Associated With Frequent Short-Term Changes in Left Ventricular Ejection Fraction Journal of Clinical Oncology ·Patrick G. Morris, Maura N. Dickler, Heather L. McArthur, Tiffany A. Traina, Steven Sugarman, Nancy U. Lin, Beverly Moy, Steven E. Come, Laura Godfrey, Benjamin Nulsen, Carol Chen, Richard M. Steingart, Hope S. Rugo, Larry Norton, Eric P. Winer, Clifford A. Hudis, Chau T. Dang	2009	22
13	Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation Transplantation and Cellular Therapy ·María Queralt Salas, Eshetu G. Atenafu, Arjun Law, Wilson Lam, Ivan Pašić, Carol Chen, Dennis Kim, Fotios V. Michelis, Armin Gerbitz, Jeffrey H. Lipton, Jonas Mattsson, Rajat Kumar, Auro Viswabandya	2021	19
14	Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer Breast Cancer Research and Treatment ·Devika Gajria, Joseph Gonzalez, Kimberly Feigin, Sujata Patil, Carol Chen, Maria Theodoulou, Pamela Drullinsky, Gabriella D’Andrea, Diana Lake, Larry Norton, Clifford A. Hudis, Tiffany A. Traina	2011	19
15	Pushing the limits of detection for proteins secreted from single cells using quantum dots The Analyst ·Vanessa García Herrera, Ssu-Chieh Joseph Hsu, Maha K. Rahim, Carol Chen, Lisa N. Nguyen, Wendy F. Liu, Jered B. Haun	2018	18
16	Long‐term cardiac safety and outcomes of dose‐dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer Cancer ·Patrick G. Morris, Neil M. Iyengar, Sujata Patil, Carol Chen, A. Abbruzzi, Robert Lehman, Richard M. Steingart, Kevin C. Oeffinger, Nancy U. Lin, B. Moy, Steven E. Come, Eric P. Winer, Larry Norton, Clifford A. Hudis, Chau T. Dang	2013	15
17	Cardiac ATTR amyloid nuclear imaging—not all bone scintigraphy radionuclide tracers are created equal Journal of Nuclear Cardiology ·Ji Can Yang, Josef Fox, Carol Chen, Anthony F. Yu	2017	15
18	Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infections Leukemia & lymphoma ·María Queralt Salas, Eshetu G. Atenafu, Arjun Law, Wilson Lam, Ivan Pašić, Carol Chen, Dennis Kim, Fotios V. Michelis, Armin Gerbitz, Jeffrey H. Lipton, Jonas Mattsson, Rajat Kumar, Auro Viswabandya	2021	13
19	Point-Of-Care Ultrasound in Resource-Limited Settings Clinical Pediatric Emergency Medicine ·Nicolaus W. Glomb, Beth D’Amico, Marideth Rus, Carol Chen	2015	13
20	Oncohistones in brain tumors: the soil and seed Trends in cancer ·Augusto Faria Andrade, Carol Chen, Nada Jabado	2023	11

About Carol Chen

Carol Chen is a scholar working on Transplantation, Hematology, Geriatrics and Gerontology, Oncology and Public Health, Environmental and Occupational Health, having authored 56 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (9 papers), Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (6 papers), Renal Transplantation Outcomes and Treatments (5 papers), Polyomavirus and related diseases (4 papers) and Genomics and Chromatin Dynamics (4 papers). The work is most often cited by research in Molecular Biology (1.1k citations), Cancer Research (222 citations), Immunology (303 citations), Oncology (341 citations) and Microbiology (67 citations). Carol Chen has collaborated with scholars based in Canada, United States and Sweden. Frequent co-authors include Robert E. W. Hancock, Raymond Lo, David J. Lynn, Fiona S. L. Brinkman, Amir Foroushani, Matthew R. Laird, Karin Breuer, Geoffrey L. Winsor, Matthew C. Lorincz and Mohammad M. Karimi. Their work appears in journals such as European Journal Of Haematology, Transplantation and Cellular Therapy, Journal of Clinical Oncology, Nature Communications and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact